Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 113 Breast Neoplasms 80 Neoplasms 75 Neoplasm Metastasis 63 Colorectal Neoplasms 63 Prostatic Neoplasms 59 Recurrence 57 Leukemia, Myeloid, Acute 55 Pancreatic Neoplasms 54 Ovarian Neoplasms 53 Multiple Myeloma 52 Melanoma 40 Glioblastoma 40 Squamous Cell Carcinoma of Head and Neck 33 Lung Neoplasms 33 Triple Negative Breast Neoplasms 31 Lymphoma, Non-Hodgkin 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Endometrial Neoplasms 30 Carcinoma, Renal Cell 28 Lymphoma 27 Lymphoma, Large B-Cell, Diffuse 26 Carcinoma, Hepatocellular 26 Stomach Neoplasms 25 Lymphoma, B-Cell 25 Small Cell Lung Carcinoma 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Brain Neoplasms 24 Advanced Solid Tumor 24 Myelodysplastic Syndromes 23

Interventions

Transdermal Patch 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cutaneous Squamous Cell Carcinoma × 90 days × Clear all

NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting

Cutaneous Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡